Paasa Logo
4D Molecular Therapeutics, Inc. logo
FDMTNASDAQMarket closedOpens 9:30am ET

4D Molecular Therapeutics, Inc.

$14.47Last updated
-$0.24 (1.63%)Past day
Timezone

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is trading at $14.47, about ₹1,388 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 1.63% today. Indian residents can buy 4D Molecular Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$14.82
Previous close:$14.71
Volume:1.02M

Today's low

$14.06

Today's high

$14.82

52 week low

$6.96

52 week high

$16.93

FDMT opened at $14.82, closed previously at $14.71, and has traded between $6.96 and $16.93 over the past 52 weeks.

About

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's developmental efforts are concentrated across a trio of therapeutic fields: ophthalmology (eye conditions), cardiology (heart ailments), and pulmonology (respiratory disorders). Within its active pipeline, three specific product candidates have advanced into clinical trial phases, all currently undergoing Phase 1/2 clinical assessment: 4D-125 is being evaluated for the treatment of X-linked retinitis pigmentosa. 4D-110 targets choroideremia. 4D-310 is focused on addressing Fabry disease. Beyond these, two Investigational New Drug (IND) candidates are in development: 4D-150, aimed at combating wet age-related macular degeneration, and 4D-710, designed to tackle cystic fibrosis lung disease. To advance its mission, 4D Molecular Therapeutics, Inc. actively engages in research and development partnerships with entities such as uniQure, CRF, Roche, and CFF. The firm commenced operations in 2013 and maintains its headquarters in Emeryville, California.

Country
US
CEO
David H. Kirn
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
196
Sector
Healthcare
IPO date
11/12/2020

Key statistics

Avg. volume

935.05K

Market cap

$756.44M

P/E Ratio

-5.32

Price-to-sales ratio

8.22

Enterprise value

$725.28M

Free cash flow yield

-20.71%

Debt-to-equity ratio

0.10

Return on equity

-41.33%

ROIC

-43.77%

Beta

2.73

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$85.21M

Earnings per share

-$2.42

Free cash flow

-$109.08M

Net profit margin

-194.74%

Gross margin

42.00%

EBITDA

-$132.48M

Revenue growth

230194.59%

Similar securities

This is not an investment recommendation

How to buy 4D Molecular Therapeutics from India

Indian residents can buy 4D Molecular Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for 4D Molecular Therapeutics and place an order

    Find 4D Molecular Therapeutics by name or by its ticker, FDMT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. 4D Molecular Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your 4D Molecular Therapeutics position in USD and INR. 4D Molecular Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in 4D Molecular Therapeutics from India

Trading and taxes when buying 4D Molecular Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
None4D Molecular Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy 4D Molecular Therapeutics stock?

Yes. 4D Molecular Therapeutics (FDMT) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one 4D Molecular Therapeutics share cost in rupees?

One 4D Molecular Therapeutics share is $14.47 — about ₹1,388 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the 4D Molecular Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying 4D Molecular Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of 4D Molecular Therapeutics?

Yes. One 4D Molecular Therapeutics share is $14.47, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in 4D Molecular Therapeutics.

How are gains on 4D Molecular Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the 4D Molecular Therapeutics price. Paasa issues a capital-gains statement for your return.

Does 4D Molecular Therapeutics pay a dividend?

No. 4D Molecular Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade 4D Molecular Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on 4D Molecular Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare 4D Molecular Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your 4D Molecular Therapeutics holding, its cost and its closing value.

How do I sell 4D Molecular Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.